http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160094345-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8d0fc2b70675ee19bd5fc464f5ae9061 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate | 2016-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a17bb7fc0a30cbd24173f639dae38167 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bf6e56ab581182c30c4c6867f282ebe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d69d6506b5961836c24ca50b6c1c39fc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c556a9c7b151fa1a0bec72cb7b2efa6 |
| publicationDate | 2016-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20160094345-A |
| titleOfInvention | Composition Comprising Verbenone Derivatives for Reducing or Preventing Side Effects of Revascularization |
| abstract | The present invention relates to a pharmaceutical composition for reducing or preventing adverse effects caused by reperfusion, and more particularly, to a pharmaceutical composition for reducing or preventing adverse effects caused by reperfusion procedures including a verbenone derivative having the structure of formula (I) or a pharmaceutically acceptable salt thereof And a method for reducing or preventing adverse effects caused by reperfusion by administering the verbenone derivative or a pharmaceutically acceptable salt thereof before, concurrently with, or after performing the reperfusion procedure. The present invention also relates to a composition for treating cerebrovascular disease, arteriosclerosis or cardiovascular disease in a patient undergoing a reperfusion procedure comprising a verbenone derivative having the structure of formula (I) or a pharmaceutically acceptable salt thereof, Atherosclerosis or cardiovascular disease by administering the verbenone derivative or a pharmaceutically acceptable salt thereof before, concurrently with, or after the administration of the verbenone derivative. |
| priorityDate | 2015-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 218.